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Title:  
Improved hepatic arterial fraction estimation using cardiac output correction of arterial input 
functions for liver DCE MRI 
Abstract (311 words) 
Liver dynamic contrast enhanced (DCE) MRI pharmacokinetic modelling could be useful in the 
assessment of diffuse liver disease and focal liver lesions, but is compromised by errors in arterial 
input function (AIF) sampling.  In this study, we apply cardiac output correction to arterial input 
functions (AIFs) for liver dynamic contrast enhanced (DCE) MRI and investigate the effect on dual-
input single compartment hepatic perfusion parameter estimation and reproducibility.  
Thirteen healthy volunteers (28.7±1.94 years, seven males) underwent liver DCE MRI and cardiac 
output measurement using aortic root phase contrast MRI (PCMRI), with reproducibility (n=9) 
measured at seven days.  Cardiac output AIF correction was undertaken by constraining the first 
pass AIF enhancement curve using the indicator-dilution principle.  Hepatic perfusion parameters 
with and without cardiac output AIF correction were compared and seven-day reproducibility 
assessed. 
Differences between cardiac output corrected and uncorrected liver DCE MRI portal venous (PV) 
perfusion (p=0.066), total liver blood flow (TLBF)(p=0.101), hepatic arterial (HA) fraction (p=0.895), 
mean transit time (MTT)(p=0.646), distribution volume (DV)(p=0.890) were not significantly 
different.  Seven-day corrected HA fraction reproducibility was improved (mean difference 0.3%, 
Bland-Altman 95% Limits-of-Agreement (BA95%LoA) ±27.9%, Coefficient of Variation (CoV) 61.4% vs 
9.3%, ±35.5%, 81.7% respectively without correction).  Seven-day uncorrected PV perfusion was also 
improved(mean difference 9.3 ml/min/100g, BA95%LoA ±506.1 ml/min/100g, CoV 64.1% vs 0.9 
ml/min/100g, ±562.8 ml/min/100g, 65.1% respectively with correction) as was uncorrected 
TLBF(mean difference 43.8 ml/min/100g, BA95%LoA ±586.7 ml/min/100g, CoV 58.3% vs 13.3 
ml/min/100g, ±661.5 ml/min/100g, 60.9% respectively with correction). Reproducibility of 
uncorrected MTT was similar (uncorrected mean difference 2.4s, BA95%LoA ±26.7s, CoV 60.8% 
uncorrected vs 3.7s, ±27.8s, 62.0% respectively with correction), as was and DV (uncorrected mean 
difference 14.1%, BA95%LoA ±48.2%, CoV 24.7% vs 10.3%, ±46.0%, 23.9% respectively with 
correction). 
Cardiac output AIF correction does not significantly affect the estimation of hepatic perfusion 
parameters but demonstrates improvements in normal volunteer seven-day HA fraction 
reproducibility, but deterioration in PV perfusion and TLBF reproducibility.  Improved HA fraction 
reproducibility maybe important as arterialisation of liver perfusion is increased in chronic liver 
disease and within malignant liver lesions. 
Keywords 
Liver DCE MRI, arterial input functions, cardiac output, pharmacokinetic modelling  
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Introduction 
Liver Dynamic Contrast Enhanced (DCE) MRI has been used to investigate diffuse parenchymal 
changes in fibrosis/cirrhosis(Annet et al., 2003; Hagiwara et al., 2008; Kim et al., 2008), but also in 
the characterisation of focal liver lesion vascularity and quantification of tumour 
angiogenesis(Jackson et al., 2002).  The technique involves acquisition of high temporal resolution 
images following intravenous administration of a gadolinium-based contrast agent (CA).  Dynamic 
changes in tissue signal intensity (SI) are recorded, converted into CA concentration, with 
quantification of tissue perfusion using pharmacokinetic modelling(Materne et al., 2002; 
Pandharipande et al., 2005; Tofts and Kermode, 1991).  
Pharmacokinetic modelling requires regions-of-interest (ROIs) to be placed over dynamically 
imaged afferent vessels to derive vascular input function (VIFs).  These are measured following a 
rate-controlled injection, ideally directly into the afferent vessel and as close as possible to the organ 
of interest.  VIFs are then convolved with tissue enhancement curves to derive inflow and outflow 
constants that reflect perfusion. 
In clinical practice, VIF sampling takes place away from both the injection site (contrast 
usually given via peripheral vein) and the organ of interest.  VIFs are therefore widened by dilution 
and patient-specific circulatory factors such as cardiac output.  In addition to this sampling of arterial 
input function (AIFs) using MRI can be particularly challenging.  Sampling of rapid changes in CA 
concentration in high flow vessels can result in dephasing effects(Oechsner et al., 2009; Utz et al., 
2008), high arterial flow velocities result in inflow effects(Peeters et al., 2004), pulsatile flow results 
in artefactual loss of signal, small vessel/ROI sizes result in partial voluming(van der Schaaf et al., 
2006) and limitations in the temporal resolution of the acquisition can omit essential AIF 
features(Gill et al., 2014).  All of these factors can result in erroneous AIF sampling.  Pharmacokinetic 
modelling using inaccurate AIFs thus introduces errors in estimated hepatic perfusion parameters. 
Liver DCE MRI has the additional complexity of dual portal venous (PV) and hepatic arterial 
(HA) blood supply, necessitating measurement of both an arterial input function (AIF) and portal 
venous input function (PVIF).  Sampling of PVIFs is less troublesome than AIFs, as the PV 
demonstrates slower flow, slower rates of CA concentration change and lower peak CA 
concentration. 
Previously, Zhang et al.(Zhang et al., 2009) have proposed using MR measurements of 
cardiac output to correct AIFs in the measurement of renal perfusion.  Using indicator-dilution 
theory:  the principle that the volume of a compartment can be estimated from knowledge of the 
concentration and volume of indicator introduced into a circulatory system, Zhang et al. used cardiac 
output measurements to correct the area under the AIF peak.  They applied their method to 
demonstrate improved precision and repeatability of estimated renal perfusion parameters (Zhang 
et al., 2009).  It is unknown if these benefits apply to more complex organs such as the liver.  We 
hypothesise that the use of cardiac output corrected AIFs in DCE MRI pharmacokinetic modelling 
would significantly influence hepatic perfusion parameter quantification, and improve their 
reproducibility. 
The purpose of the study was therefore to apply the principal of cardiac output correction of 
AIFs described by Zhang et al. to estimate hepatic DCE MRI perfusion parameters using the dual 
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input single compartment model (Materne et al., 2002; Materne et al., 2000; Miyazaki et al., 2008) 
in healthy volunteers and to evaluate the effects of cardiac output corrected AIFs on DCE MRI 
hepatic perfusion parameters and their seven-day reproducibility.  
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Materials and Methods 
Subjects and preparation 
The study was approved by the Local Ethics Committee and all participants provided informed 
written consent.  Advertisement within the university campus was used to recruit volunteers who 
were eligible only if (a) they had no contraindications to MRI, (b) they were not taking any long-term 
medication (excluding oral contraception) and (c) had no past history of gastrointestinal or liver 
disease.  Fourteen volunteers were recruited, but one was excluded due to claustrophobia.  Seven 
males (aged 26.5±1.36 years) and six females (aged 31.2±2.62 years) participated in the study.  All 
subjects fasted for six hours before the MRI scan and avoided caffeinated fluids.  A peripheral upper 
limb vein was cannulated (19G) in preparation for administration of intravenous contrast.  Nine 
subjects consented to be re-scanned seven days after the original scan for reproducibility studies.  
These subjects followed identical preparation and MRI protocol, and were scanned at a comparable 
time of day as the first study (within 2 hours).  This cohort has previously been described(Chouhan et 
al., 2016a), where the effects of altering VIF CA bolus arrival delays on liver DCE MRI perfusion 
parameters were investigated.  The current study presents new data on cardiac output correction of 
AIFs. 
DCE MRI 
Imaging was performed using a 3.0T scanner (Achieva, Philips Healthcare, Best, Netherlands) using a 
16 channel body coil (SENSE XL-Torso, Philips Healthcare, Best, Netherlands) as previously described 
(Chouhan et al., 2016a).  Briefly, anatomical imaging using a breath hold balanced steady-state free 
precession (SSFP) sequence was used to plan DCE studies for inclusion of the liver, retroperitoneal 
vessels and heart.  T1 measurements were obtained using multi-flip angle (5, 7, 10, 15 and 20˚) 
three-dimensional (3D) gradient echo imaging, with B1 non-uniformity correction (Treier et al., 
2007).  Three-dimensional gradient Turbo Field echo (TFE) imaging with spectral attenuated 
inversion recovery (SPAIR) fat suppression was used for coronal plane DCE imaging.  Sixty slices were 
obtained from each 15 cm volume within 3.35 seconds, with sequential scanning for five minutes 
(sequence parameters given in table 1).  Ten ml of Gd-DOTA (gadoterate dimeglumine, Dotarem®, 
Guerbet, Roissy, France), diluted in 10 ml of normal saline, was injected after the first five volumes 
were acquired at 4 ml/s (Spectris®, Medrad Inc., USA), followed by a 20 ml saline flush.  The first 
breath hold instruction was given before the CA injection and subjects thereafter continued self-
directed expiration breath holds for the remainder of the DCE study. 
Cardiac output measurement using phase contrast MRI 
Cardiac output was measured at the aortic root.  The study coordinator (Blind, radiology research 
fellow with 5 years’ experience in abdominal imaging) planned two-dimensional cine PCMRI with 
expiratory breath-hold and retrospective cardiac gating using the previously acquired anatomical 
SSFP images. Planning was undertaken in two planes to ensure orthogonality to the aortic root (table 
1). Studies were performed using a velocity encoding (    ) setting of 120 cm/s, and images were 
reviewed for aliasing with      settings increased when appropriate.  PCMRI measurements were 
performed using seven phases through the cardiac cycle and acquired three times in succession, 
over three breath holds.  Aortic root PCMRI studies were repeated after seven days for 
reproducibility studies. 
Page 5 of 21 AUTHOR SUBMITTED MANUSCRIPT - PMB-104572.R2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
M
an
us
rip
t
6 
 
Post-processing 
Post-processing was performed using Matlab code (MathWorks, Natick, USA) developed in house as 
described previously(Chouhan et al., 2016a).  Briefly, motion artefacted DCE volumes were discarded 
- no VIF peaks were missed.  Five coronal slices each separated by 10 mm and centred around the 
portal vein, were selected for analysis.  Slices were matched to previously derived T1 maps and 
robust data decomposition registration was applied to correct for tissue displacement and 
deformation(Hamy et al., 2014).  Where signal intensity (SI) data was missing due to discarded 
volumes, these were estimated using linear interpolation.  SI maps were then converted on a pixel-
wise basis into CA concentration maps for each of the five slices (Aronhime et al., 2014; Gill et al., 
2014).  Hepatic parenchymal ROIs were positioned to avoid major inflow or outflow vessels, firstly in 
the right upper region (segments VII/VIII), left liver (segments II/III) and right lower region (segments 
V/VI).  Three ROIs were positioned on each of the five slices.  For each VIF, ROIs were also placed in 
the left ventricle chamber and PV as demonstrated previously (Chouhan et al., 2016a).  Perfusion 
parameters (detailed below) extracted from all fifteen ROIs (three ROIs on five slices) were averaged 
across all subjects for comparative studies. 
Aortic root flow was quantified from PCMRI data using freely available software (Segment, 
Medviso, Lund, Sweden) and multiplied by the contemporaneous heart rate to estimate cardiac 
output.  The mean of triplicate cardiac output measurements was used for analysis.  All post-
processing was undertaken by the study coordinator. 
AIF correction using cardiac output measurements 
Based on the method described by Zhang et al. (Zhang et al., 2009), AIFs expressed as the 
concentration of CA as function of time (     ), were converted back into their raw SI curves (     ).  
The peak and main decline in concentration of the raw SI AIF was then extrapolated and fitted with 
the gamma variate function to derive an expression for first pass SI (      )(Davenport, 1983): 
                  
            
(Equation 1) 
where, ‘  ’ represents baseline SI, ‘  ’ is the AIF delay and ‘ ’, ‘ ’ and ‘ ’ are fitted parameters.  The 
first pass SI curve (      ) can then be converted back into a first pass AIF CA curve (      ).  Using 
the indicator-dilution principle: 
∫          
 
 
 
(Equation 2) 
 
where, ‘ ’ is the mass of injected extracellular CA and ‘ ’ is the bulk flow.  As ‘ ’ is known and ‘ ’ 
was measured independently using PCMRI aortic root flow, ‘      ’ area under the curve (AUC) 
could be adjusted to represent the expected first pass CA concentration curve based on known 
cardiac output.  This adjusted first pass CA concentration curve could then be converted back into 
corrected raw first pass SI data.  The converted SI curves could then be used to derive a new 
estimate for baseline signal intensity (   ). 
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 In the final steps, the raw SI curves for the entire AIF (including the recirculated portion) are 
shifted a new baseline (   ).  The new corrected raw SI AIF is then converted back to a corrected AIF 
CA concentration curve (      ), ready for use in pharmacokinetic modelling.  AIF correction factors 
were derived by expressing the area under the        curve as a percentage of the area under the 
      curve. 
Pharmacokinetic modelling 
Dual-input single compartment modelling was undertaken as reported previously(Hagiwara et al., 
2008; Materne et al., 2002).  Briefly, liver parenchymal CA concentration as a function of time 
(     ) can be expressed as: 
       ∫ [       
            ( 
    )] 
   (   
 )   
 
 
  
(Equation 3) 
 
where       represents the arterial input CA concentration as a function of time,       represents 
the PV input CA concentration as a function of time,    represents the arterial inflow constant, 
   represents the PV inflow constant,    represents the outflow constant,    represents the delay 
between the arrival of CA in the AIF and parenchymal ROIs and    represents the delay between 
arrival of CA in the PVIF and parenchymal ROIs.  Model fitting was undertaken firstly using pre-
estimation of CA bolus arrival delays with constrained free modelling(Chouhan et al., 2016a), 
followed by non-linear least squares fitting with in house developed Matlab code.  Inflow and 
outflow constants were used to derive estimates of PV perfusion (ml/min/100g), total liver blood 
flow (TLBF, sum of HA and PV perfusion, ml/min/100g), HA fraction (%), distribution volume (DV, %) 
and mean transit time (MTT, seconds) as reported previously(Hagiwara et al., 2008; Materne et al., 
2002).  Pharmacokinetic modelling was undertaken using both the measured (     ) and corrected 
AIF (      ) and the residual sum of squares was recorded as a measure of model fitting. 
Statistical analysis 
Kolmogorov-Smirnov tests were used to confirm the normality of variable distributions.  Paired t-
tests/Wilcoxon matched pairs signed rank tests were used to compare perfusion parameters derived 
from cardiac output corrected and uncorrected AIF data.  Seven-day reproducibility studies were 
assessed using Bland-Altman (BA) analysis of agreement, with calculation of the mean difference 
(bias), 95% Limits of Agreement (LoA) and coefficients of variation and compared for cardiac output 
corrected and uncorrected AIF data.  Data was expressed as mean±standard error and statistical 
significance was assigned at p<0.05. 
Results 
Cardiac output correction of AIFs for estimation of hepatic perfusion parameters 
Across the cohort, mean cardiac output was 4143±148 ml/min, ranging from 2918-5359 ml/min.  
The mean difference for repeated cardiac output measurements (n=9) was 82.23 ml/min (figure 1), 
with BA 95% LoAs of ±1358 ml/min and coefficients of variation of 18.48% (inter-subject) and 5.85% 
(intra-subject).  Figure 2 illustrates the uncorrected AIF, uncorrected and first pass AIF SI curve with 
gamma variate fit, corrected first pass CA concentration curve and corrected AIF from a sample data 
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set.  Mean AIF correction factor was 98.12±5.34% (range 52.05-165.1%, coefficient of variation 
25.54%figure 3). 
Perfusion parameters and residual sum of squares for model fitting across the sample are presented 
for uncorrected and corrected AIFs in figure 4 and table 2.  DV and residual sum of squares failed 
normal distribution testing and therefore underwent non-parametric statistical testing.  No 
significant differences were demonstrated between uncorrected and corrected AIF perfusion 
parameters (PV perfusion mean difference 17.3±8.9 ml/min/100g, p=0.0666; TLBF mean difference 
19.1±11.1 ml/min/100g, p=0.1016; HA fraction mean difference -0.3±2.0%, p=0.8952; MTT mean 
difference -0.2±1.8s, p=0.6462; and DV median difference 0.0%, p=0.8900) or model fitting (residual 
sum of squares median difference 2.2x10-10, p=0.4169). 
Reproducibility studies 
Reproducibility was assessed in 9 normal volunteers seven days after the initial study (table 3, figure 
5).  The mean difference for repeated PV perfusion and TLBF measurements was smallest using 
corrected AIFs (0.92 vs 9.31 ml/min/100g for corrected and uncorrected AIF PV perfusion and 13.32 
vs 43.75 ml/min/100g for corrected and uncorrected AIF TLBF respectively). 
The BA 95% LoAs for both these perfusion parameters were however smaller using 
uncorrected AIFs (±562.8 vs ±506.1 ml/min/100g for corrected vs uncorrected AIF PV perfusion; and 
±661.5 vs ±586.7 ml/min/100g for corrected vs uncorrected AIF TLBF).  The coefficient of variation 
for both corrected and uncorrected AIF PV perfusion (65.10% corrected vs 64.05% uncorrected) and 
TLBF (60.85% corrected vs 58.29% uncorrected) were similar for both methods. 
The mean difference between repeated HA fraction measurements was smallest using 
corrected AIFs (0.32%).  This method demonstrated the smallest BA 95% LoAs (±27.85% corrected vs 
±35.49% uncorrected).  The coefficient of variation was also smallest using corrected AIFs (61.36% 
corrected vs 81.71% uncorrected). 
The smallest mean difference for repeated MTT measurements was demonstrated using 
uncorrected AIFs (2.37 seconds) but the smallest mean difference for repeated DV measurements 
was demonstrated using corrected AIFs (10.26%).  Both BA 95% LoAs and coefficients of variation 
were similar across both methods for both MTT and DV. 
Discussion 
The measurement of hepatic vascular parameters has important potential applications in the 
evaluation of chronic liver disease(Mookerjee, 2011) and focal liver lesions(Jackson et al., 2002).  The 
haemodynamic changes underpinning these conditions however remain poorly understood because 
of highly invasive methods required for accurate measurement(Chouhan et al., 2016b). 
Liver DCE MRI is a powerful non-invasive tool to investigate pathological haemodynamic 
changes, but quantification is based on models reliant on measurement of VIFs (Annet et al., 2003; 
Hagiwara et al., 2008; Materne et al., 2002).  Measurement of the AIF using MRI is troublesome and 
in this study we evaluate a previously proposed method in which independent measurements of 
cardiac output are used to correct AIFs (Zhang et al., 2009).  Unlike other organs which possess a 
single afferent blood supply, pharmacokinetic modelling in the liver is uniquely challenging because 
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of reliance on a two separate vascular input functions.  The effects of cardiac output AIF correction 
are therefore unknown in the liver and this is to our knowledge, the first evaluation of the effects of 
cardiac output AIF correction on dual-input single compartment modelling for measurement of 
hepatic perfusion parameters. 
We have demonstrated that while the use of cardiac output AIF correction can cause both 
increases and decreases in sampled AIFs, such corrections on average had no significant effect on 
estimated hepatic perfusion parameters and model fitting compared to uncorrected data.  While AIF 
correction did reduce the mean difference between perfusion parameters after 7 days (with the 
exception of MTT), the BA 95% LoA was only improved for HA fraction, with comparable or inferior 
reproducibility for all other parameters.  Furthermore, whilst cardiac output AIF correction improved 
the HA fraction coefficient of variation, the coefficient of variation for all other perfusion parameters 
was comparable to those obtained using uncorrected AIFs. 
The attraction of using cardiac output correction is the use of an independently measured 
patient-specific parameter for correction.  Systemic haemodynamic factors such as cardiac output 
can be altered in chronic liver disease(Mehta et al., 2014) and while the specific effect of cardiac 
output changes on hepatic perfusion parameters are unknown, we would argue that individualised 
correction avoids the potential assumptive errors introduced by using alternative methods such as 
general population-derived AIFs (Parker et al., 2006).  Cardiac output AIF correction is however 
reliant on the derivation of a first pass curve using a gamma variate function: an established 
technique in nuclear medicine, but one that has had limited application to MRI AIFs.  The method of 
AIF correction is also based upon altering the baseline raw SI (  ) to a new estimated baseline SI 
(   ), which secondarily affects the AIF CA concentrations throughout the rest of the sampled curve.  
The method thus addresses errors in AIF sampling that arise from measurement of blood pool T1 
and inflow effects, but assumes that the fundamental morphology of the sampled AIF curve is 
correct.  Dephasing (T2*) effects at peak AIF CA concentrations – an issue particularly when scanning 
at higher field strength – are therefore not addressed and remain a major potential source of error 
(Lee, 1991). 
Pharmacokinetic modelling is also reliant on sampling of the PVIF as well as the AIF.  
Correction of one without the other would in principle affect estimated perfusion parameters.  
Unlike AIF curves, PVIF curves are less prone to VIF sampling errors, demonstrating a slow CA 
concentration rise, and lower peak CA concentration, compatible with slower, relatively non-
pulsatile splanchnic flow.  Derivation of a first pass curve using the methods employed would 
therefore be unfeasible.  Correction of the PVIF curve by simply assuming the new estimated 
baseline SI (   ), would only be acceptable if raw baseline SI at the site of AIF and VIF sampling were 
identical – a phenomenon which is not supported by theory, published data (Dobre et al., 2007; 
Zhang et al., 2013) or the data collected in this study. 
While our derived absolute perfusion parameters (PV perfusion and TLBF) are comparable to 
published DCE MRI data (Aronhime et al., 2014), these values are still much higher than would be 
expected physiologically(Kuo et al., 1995; Mehta et al., 2014; Soons et al., 1991).  There is also 
limited published data on the reproducibility of liver DCE MRI using dual-input single compartment 
modelling(Chouhan et al., 2016a), but our data demonstrates relatively wide BA 95% LoAs for 
absolute perfusion parameters.  This may reflect natural variation in perfusion, contingent on 
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differences in subject hydration (as supported by the observed reproducibility of data for cardiac 
output measurements), but may also be secondary to the many other challenges in performing 
clinical DCE MRI not directly addressed by the present study. 
Zhang et al., were able to use cardiac output AIF correction to demonstrate absolute renal 
perfusion (glomerular filtration rate) standard deviation reductions and stronger linear correlations 
across repeated measurements in four subjects(Zhang et al., 2009).  Our findings may reflect the 
greater variability introduced by dual-input modelling, and also highlight that PVIFs (the main 
contributor to PV and therefore TLBF perfusion) were unchanged for modelling of both uncorrected 
and cardiac output corrected data.  Finally, it is worth noting that the overall study size was small.  
Arterial contributions to hepatic perfusion are small in healthy tissue, thereby further compromising 
study power. 
This study adds to current knowledge by evaluating a previously proposed method for 
correcting a recognised source of error in DCE MRI pharmacokinetic modelling, in the context of liver 
perfusion measurement.  Errors in MRI AIF sampling remain an important limitation of DCE MRI in 
the liver and elsewhere in the body.  Evaluation of the benefits or otherwise of cardiac output 
correction on liver DCE MRI perfusion parameter estimation is important if we are to determine 
robust strategies for accurate and reproducible liver DCE MRI in the clinical setting.  Our data 
suggests that the clinical value of cardiac output AIF correction for DCE of the liver is debatable:  the 
time taken for acquisition and analysis of PCMRI cardiac output measurements, combined with the 
added complexity involved in correcting the AIF are important barriers to implementation.  It could 
be argued that the improved reproducibility and reduced coefficient of variation of HA fraction is an 
important advantage, outweighing the apparent deleterious effects on the reproducibility of 
estimated absolute perfusion parameters (PV perfusion and TLBF), particularly in the context of 
general overestimation of PV perfusion and TLBF by DCE MRI. Increases in relative arterialisation of 
tissues (as measured by HA fraction) are important pathophysiological sequelae of chronic liver 
disease and focal malignant lesions, thus underlining the potential value of using cardiac output AIF 
correction for measurement of HA fraction. 
Conclusion 
AIFs correction using PCMRI aortic flow measurements has limited effect on estimated dual-input 
single compartment hepatic perfusion parameters and does not improve the reproducibility of PV 
perfusion and TLBF measurements. AIF correction does however have apparent advantages in 
improving the reproducibility of HA fraction.  This finding has potential importance because 
arterialisation of liver perfusion is increased in chronic liver disease and within malignant liver 
lesions. 
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Tables 
 
Table 1: Sequence parameters 
 
 T1 MULTI-FLIP 
ANGLE 
B1 MAP DCE MRI PCMRI 
TR/TE (seconds) 4.0/2.0 100/1.0 2.0/1. 0 8.70/5.22 
Flip angle (˚) 5, 7, 10, 15, 20 60 10 10 
Matrix size (pixels) 240 x 240 100 x 100 240 x 240 336 x 336 
Field-of-view (mm) 475 x 475 475 x 475 475 x 475 271 x 210 
Spatial resolution 
(mm2) 
1.98 x 1.98 4.75 x 4.75 1.98 x 1.98 0.808 x 0.625 
Bandwidth 
(Hz/pixel) 
389 1447 1411 210 
Slice thickness (mm) 5 5 5 5 
Slice gap (mm) 2.5 5 2.5 - 
Slices per volume 60 30 60 - 
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Table 2: Perfusion parameters estimated using the dual input single compartment model, 
with and without cardiac output AIF correction 
 UNCORRECTED AIF CORRECTED AIF  
 MEAN±SE 95% CI MEAN±SE 95% CI P-VALUE 
PV perfusion (ml/min/100g) 274.3±38.4  (194.3, 354.3) 291.6±41.4 (205.2, 378.0) 0.066 
TLBF (ml/min/100g)  327.5±41.7  (240.6, 414.4) 346.6±46.0 (250.6, 442.7) 0.101 
HA fraction (%) 20.7±3.7  (13.0, 28.4) 20. 5±2.7 (14.7, 26.2) 0.895 
Mean Transit Time (s) 19.9±2.6  (14.4, 25.4) 19.7±2.7 (14.2, 25.3) 0.646 
Distribution Volume (%) 73.5±4.0 (65.2, 81.7) 73.7±3.8 (65.7, 81.7) 0.890 
Residuals2 4.7x10-7±7.8x10-8  (2.9x10-7, 6.2 x10-7) 5.2x10-7±1.2x10-7 (2.6x10-7, 7.8x10-7) 0.417 
(standard error (SE), confidence interval (CI), with no significant differences demonstrated between uncorrected and 
corrected AIF perfusion parameters) 
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Table 3: Summary of reproducibility of perfusion parameters estimated using the dual 
input single compartment model, with and without cardiac output AIF correction 
 
 UNCORRECTED AIF 
DUAL INPUT SINGLE COMPARTMENT 
CORRECTED AIF 
DUAL INPUT SINGLE COMPARTMENT 
PV perfusion 
(ml/min/100g) 
Mean difference 
BA 95% LoA 
Coefficient of Variation  
 
 
9.31 
±506.1 
64.05% 
 
 
0.92 
±562.8 
65.10% 
TLBF (ml/min/100g) 
Mean difference 
BA 95% LoA 
Coefficient of Variation 
 
43.75 
±586.7 
58.29% 
 
13.32 
±661.5 
60.85% 
HA fraction (%) 
Mean difference 
BA 95% LoA 
Coefficient of Variation 
 
9.26 
±35.49 
81.71% 
 
0.32 
±27.85 
61.36% 
Mean Transit Time 
(seconds) 
Mean difference 
BA 95% LoA 
Coefficient of Variation 
 
 
2.37 
±26.89 
60.84% 
 
 
3.66 
±27.79 
61.96% 
Distribution Volume (%) 
Mean difference 
BA 95% LoA 
Coefficient of Variation 
 
14.14 
±48.24 
24.66% 
 
10.26 
±46.02 
23.92% 
(Emboldened values in the table highlight the best performing method for each statistic) 
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Figure legends 
Figure 1: Pairwise changes in cardiac output and 7 day reproducibility 
Cardiac output measured at baseline and after 7 days, (a) as a ladder chart to demonstrate pairwise 
changes (p=0.7450) and (b) for Bland-Altman reproducibility analysis. 
Figure 2: Cardiac output AIF correction 
The uncorrected AIF (a), is converted back into raw signal intensity (b, blue curve).  The first past 
portion of the SI curve is modelled using the gamma variate function (b, red curve).  The SI gamma 
variate function is then converted back to derive a first pass CA concentration curve (c, blue curve) 
and adjusted using cardiac output data (c, red curve).  This is then converted back into raw SI data 
(d).  The corrected first-pass curve will provide an alternate estimate for baseline SI.  The original AIF 
raw SI curve is then adjusted to the new baseline (e).  The new adjusted curve is used to derive a 
corrected AIF CA concentration curve (f, red curve). 
Figure 3: Effects of cardiac output correction on AIF size 
On both diagrams, the corrected AIF is shown in red and the uncorrected AIF is show in dashed 
green.  In some instances, correction resulted in little or no change to the AIF itself, as shown by the 
dataset in (a), some cases (n=11) demonstrated a reduction in AIF size (b), while others 
demonstrated an increase (n=11) as shown by the dataset in figure 1f.  Pairwise changes in AIF 
correction factor at baseline and after 7 days (p=0.4931) are shown in (c). 
Figure 4: Effects of AIF correction on dual-input single compartment hepatic perfusion parameter 
estimation 
Box and whisker plots for each of the perfusion parameters demonstrate the distribution of (a) PV 
perfusion, (b) TLBF, (c) HA fraction, (d) MTT, (e) DV and (f) residual sum of squares from 
pharmacokinetic modelling using uncorrected AIF data on the left and corrected AIF data on the 
right. 
Figure 5: Analysis of agreement of perfusion parameter reproducibility using uncorrected and 
corrected AIFs with dual-input single compartment modelling 
Bland-Altman reproducibility analysis of PV perfusion (a, b), TLBF (c, d), HA fraction (e, f), MTT, (g, h) 
and DV (i, j) using uncorrected (a, c, e, g and i) and corrected (b, d, f, h, and j) AIFs.  
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Figures 
 
 
 
 
Figure 1 
 
  
(b) (a) 
Page 17 of 21 AUTHOR SUBMITTED MANUSCRIPT - PMB-104572.R2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d M
an
us
cri
pt
18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 
0 100 200 300
-0.01
0
0.01
0.02
0.03
0.04
0.05
0 100 200 300
0
1000
2000
3000
4000
5000
0 100 200 300
-0.01
0
0.01
0.02
0.03
0.04
0.05
0.06
0 100 200 300
0
1000
2000
3000
4000
5000
0 100 200 300
0
1000
2000
3000
4000
5000
0 100 200 300
-0.02
0
0.02
0.04
0.06
0.08
0.1
Time (seconds) 
G
d
-D
O
T
A
 (
m
l/
L)
 
Time (seconds) 
Si
gn
a
l I
n
te
n
si
ty
 
(b) (a) 
— AIF raw SI 
— First pass gamma 
variate fit 
 
Time (seconds) 
G
d
-D
O
T
A
 (
m
l/
L)
 
Time (seconds) 
G
d
-D
O
T
A
 (
m
l/
L)
 
Time (seconds) 
Si
gn
a
l I
n
te
n
si
ty
 
Time (seconds) 
Si
gn
a
l I
n
te
n
si
ty
 
(d) (c) 
(f) (e) 
— First pass 
AIF [CA] 
— Corrected 
first pass 
AIF [CA] 
 
— First pass 
AIF SI 
— Corrected 
first pass 
AIF SI 
 
Baseline SI = 722.6 
Corrected Baseline SI = 690.7 
— AIF SI 
— Corrected 
AIF SI 
 
- - - Uncorrected AIF 
— Corrected AIF 
 
Page 18 of 21AUTHOR SUBMITTED MANUSCRIPT - PMB-104572.R2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d M
an
us
cri
pt
19 
 
 
  
 
 
 
 
Figure 3 
 
  
0 100 200 300
-0.01
0
0.01
0.02
0.03
0.04
0 100 200 300 
-0.005 
0 
0.005 
0.01 
0.015 
0.02 
0.025 
Time (seconds) 
G
d
-D
O
T
A
 (
m
l/
L)
 
Time (seconds) 
G
d
-D
O
T
A
 (
m
l/
L)
 
(b) (a) 
- - - Uncorrected AIF 
— Corrected AIF 
 
(c) 
Page 19 of 21 AUTHOR SUBMITTED MANUSCRIPT - PMB-104572.R2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d M
an
us
cri
pt
20 
 
  
  
 
 
Figure 4 
 
  
(b) (a) 
(d) (c) 
(f) (e) 
Page 20 of 21AUTHOR SUBMITTED MANUSCRIPT - PMB-104572.R2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d M
an
us
cri
pt
21 
 
  
  
  
  
  
Figure 5 
 
(b) (a) 
(d) (c) 
(f) (e) 
(h) (g) 
(j) (i) 
Page 21 of 21 AUTHOR SUBMITTED MANUSCRIPT - PMB-104572.R2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d M
an
us
cri
pt
